Literature DB >> 2551552

Antigen-specific suppressor T lymphocytes in man.

N K Damle1, E G Engleman.   

Abstract

The cellular signals that lead to activation of suppressor T cells (Ts) as opposed to cytotoxic T cells (CTL) are unknown. This review describes an in vitro suppressor-induction system developed by us to characterize interactions among various T cells leading to the development of antigen-specific suppression. In this system, antigen-specific CD4+ inducer T cells are first activated with antigen-presenting cells (APC). Antigen-primed CD4+ inducer blasts are then cultured with fresh autologous CD8+ T cells in the absence of the priming antigen. CD8+ T cells isolated from this culture suppress the proliferative response of autologous CD4+ T cells to the priming antigen only. The activated CD8+ Ts lyse neither APC nor antigen-primed CD4+ inducer T cells and can be distinguished from their CD8+CD28+ CTL counterpart by their lack of expression of the CD28 molecule. Furthermore, the ability to induce CD8+ Ts is restricted to antigen-primed CD4+CD29+CD45R-p80+ (Leu8+) T cells. Antibody-mediated inhibition experiments suggest the involvement of CD3/TCR and class I MHC molecules on the surface of CD4+ inducer T cells and the CD2, CD3/TCR, CD8, and CD11a/CD18 molecules on the surface of CD8+ Ts during both the induction and the effector phase of Ts function. Furthermore, compatibility at the class I MHC genes between CD8+ Ts and CD4+ antigen-reactive T cells is required for effective suppression of CD4+ T cells. Together, these results suggest that human antigen-specific CD8+ Ts employ the TCR complex to recognize TCR and class I MHC molecules on the surface of autologous CD4+ inducer T cells during the induction and effector phases of Ts function, and the apparent antigen specificity of suppression reflects specificity for antigen receptors on CD4+ antigen-reactive T cells. This may be a common mechanism by which antigen-specific suppression is accomplished.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551552     DOI: 10.1016/0090-1229(89)90066-4

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism.

Authors:  Kenneth K Wong; Matthew J Carpenter; Lesley L Young; Susan J Walker; Grahame McKenzie; Alyson J Rust; George Ward; Laura Packwood; Karen Wahl; Luc Delriviere; Gerard Hoyne; Paul Gibbs; Brian R Champion; Jonathan R Lamb; Margaret J Dallman
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 2.  Experimental autoimmune uveitis: molecular mimicry and oral tolerance.

Authors:  V K Singh; K Nagaraju
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

3.  Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.

Authors:  K E Balashov; S J Khoury; D A Hafler; H L Weiner
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8- cells, in autoimmune thyroid disease.

Authors:  Y Iwatani; Y Hidaka; F Matsuzuka; K Kuma; N Amino
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

5.  Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats.

Authors:  R Olivenstein; P M Renzi; J P Yang; P Rossi; S Laberge; S Waserman; J G Martin
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

6.  Common gamma chain cytokines promote rapid in vitro expansion of allo-specific human CD8+ suppressor T cells.

Authors:  Yuming Yu; Jennifer R Zitzner; Josetta Houlihan; Nancy Herrera; Luting Xu; Joshua Miller; James M Mathew; Anat R Tambur; Xunrong Luo
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.